Germline Doping for Heightened Performance in Sport

Publication Title

Australian and New Zealand Sports Law Journal

Authors

• Lucille N. Tournas, Arizona State UniversityFollow
• Walter Johnson, Georgia State University College of LawFollow
• Andrew Maynard
• Diana M. Bowman, Royal Melbourne Institute of TechnologyFollow

Document Type

Article

Publication Date

1-2017

Abstract

In recent years, gene editing techniques such as CRISPR-cas9 have begun to enable the genetic makeup of organisms - including humans - to be precisely designed and engineered. Human embryonic gene editing is both nascent and highly contentious, with many within the scientific community cautioning against its use. However, given the long history of new technologies being used to confer a competitive advantage in sport, it is likely only a matter of time before human embryonic germline editing is explored to heighten athletic performance. As the technology develops, there is an urgent need to better-understand the legal landscape around germline doping to ensure the safety and wellbeing of athletes, and the integrity and value of the sports they participate in.

Recommended Citation

Lucille Tournas, Walter Johnson, Andrew Maynard, & Diana Bowman, Germline Doping for Heightened Performance in Sport, 12 Austl. & N.Z. Sports L. J. 1 (2017).

Institutional Repository Citation

Lucille N. Tournas, Walter Johnson, Andrew Maynard & Diana M. Bowman, Germline Doping for Heightened Performance in Sport, Faculty Publications By Year 3806 (2017)
https://readingroom.law.gsu.edu/faculty_pub/3806

Volume

12

Issue

1

First Page

1

Last Page

24